JP7714571B2 - テルペンフェノール化合物およびそれらの使用 - Google Patents

テルペンフェノール化合物およびそれらの使用

Info

Publication number
JP7714571B2
JP7714571B2 JP2022560311A JP2022560311A JP7714571B2 JP 7714571 B2 JP7714571 B2 JP 7714571B2 JP 2022560311 A JP2022560311 A JP 2022560311A JP 2022560311 A JP2022560311 A JP 2022560311A JP 7714571 B2 JP7714571 B2 JP 7714571B2
Authority
JP
Japan
Prior art keywords
pet
cbd
compound
pharmaceutically acceptable
hydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022560311A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023520794A5 (https=
JP2023520794A (ja
Inventor
ストット,コリン・ジョージ
ヒープ,チャールズ・アール
グルサンカー,ラマムーシー
Original Assignee
フィトセラピューティクス・リミテッド
アリノバ・バイオサイエンシズ・リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by フィトセラピューティクス・リミテッド, アリノバ・バイオサイエンシズ・リミテッド filed Critical フィトセラピューティクス・リミテッド
Publication of JP2023520794A publication Critical patent/JP2023520794A/ja
Publication of JP2023520794A5 publication Critical patent/JP2023520794A5/ja
Application granted granted Critical
Publication of JP7714571B2 publication Critical patent/JP7714571B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/32Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions without formation of -OH groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/38Alcohols containing six-membered aromatic rings and other rings and having unsaturation outside the aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/001Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain
    • C07C37/003Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain by hydrogenation of an unsaturated part
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/11Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms
    • C07C37/14Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms by addition reactions, i.e. reactions involving at least one carbon-to-carbon unsaturated bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/15Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/23Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09Geometrical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2022560311A 2020-03-31 2021-03-31 テルペンフェノール化合物およびそれらの使用 Active JP7714571B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063003270P 2020-03-31 2020-03-31
US63/003,270 2020-03-31
PCT/GB2021/050812 WO2021198692A1 (en) 2020-03-31 2021-03-31 Terpenophenolic compounds and their use

Publications (3)

Publication Number Publication Date
JP2023520794A JP2023520794A (ja) 2023-05-19
JP2023520794A5 JP2023520794A5 (https=) 2024-04-11
JP7714571B2 true JP7714571B2 (ja) 2025-07-29

Family

ID=75426633

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022560311A Active JP7714571B2 (ja) 2020-03-31 2021-03-31 テルペンフェノール化合物およびそれらの使用

Country Status (12)

Country Link
US (2) US12552733B2 (https=)
EP (1) EP4126800A1 (https=)
JP (1) JP7714571B2 (https=)
KR (1) KR20230121960A (https=)
CN (1) CN116194431B (https=)
AU (1) AU2021248627A1 (https=)
BR (1) BR112022019616A2 (https=)
CA (1) CA3177186A1 (https=)
GB (2) GB2609814B (https=)
IL (1) IL296861A (https=)
MX (1) MX2022011832A (https=)
WO (1) WO2021198692A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3179235A1 (en) * 2019-05-23 2020-11-26 Kare Chemical Technologies Inc. Catalytic cannabinoid processes and precursors

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020041326A1 (en) 2018-08-20 2020-02-27 Berkowitz Barry A Applications of known and novel cannabinoids
WO2020232545A1 (en) 2019-05-23 2020-11-26 Kare Chemical Technologies Inc. Catalytic cannabinoid processes and precursors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL136839A (en) * 2000-06-16 2006-12-10 Yissum Res Dev Co Pharmaceutical compositions comprising cannabidiol derivatives, and processes for the preparation of same
CA2623723A1 (en) 2005-09-29 2007-04-12 Amr Technology, Inc. Process for production of delta-9-tetrahydrocannabinol
DK2176208T3 (en) * 2007-07-30 2015-04-27 Zynerba Pharmaceuticals Inc Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof
DE102009019322A1 (de) * 2009-04-30 2010-11-11 The Health Concept Gmbh Verfahren zur Herstellung von Synthetischen Cannabinoiden
TWI583374B (zh) * 2010-03-30 2017-05-21 Gw伐瑪有限公司 使用植物大麻素次大麻二酚(cbdv)來治療癲癇之用途
WO2014177593A1 (en) 2013-04-29 2014-11-06 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Amorfrutin analogs as ppargamma-modulators
US9526706B1 (en) 2015-06-16 2016-12-27 Hong Kong Baptist University Method of using dihydro-resveratrol for treating acute pancreatitis and associated pulmonary injury
US9738581B2 (en) * 2015-06-16 2017-08-22 Hong Kong Baptist University Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions
US10059683B2 (en) 2015-07-10 2018-08-28 Noramco, Inc. Process for the production of cannabidiol and delta-9-tetrahydrocannabinol
AU2017250303B2 (en) 2016-04-15 2019-09-26 Teewinot Technologies Limited Biosynthesis of cannabinoid prodrugs
JP2019523228A (ja) 2016-06-16 2019-08-22 ティーウィノット テクノロジーズ リミテッド カンナビノイドプロドラッグの製造のための方法、薬学的製剤、およびその使用
US10640482B2 (en) 2017-07-21 2020-05-05 University Of South Florida Synthesis of cannabinoids
SG11202001725SA (en) * 2017-09-01 2020-03-30 Pureform Global Inc Synthetic cannabidiol compositions and methods of making the same
AU2020345656A1 (en) * 2019-09-09 2022-04-21 Kare Chemical Technologies Inc. Cannabinoid derivatives, precursors and uses
WO2021046640A1 (en) * 2019-09-10 2021-03-18 Kare Chemical Technologies Inc. Cannabinoid derivatives and precursors, and asymmetric synthesis for same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020041326A1 (en) 2018-08-20 2020-02-27 Berkowitz Barry A Applications of known and novel cannabinoids
WO2020232545A1 (en) 2019-05-23 2020-11-26 Kare Chemical Technologies Inc. Catalytic cannabinoid processes and precursors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CROMBIE, Leslie W. et al.,Synthesis of bibenzyl Cannabinoids, Hybrids of Two Biogenetic Series Found in Cannabis sativa,Journal of the Chemical Society, Perkin Transaction 1,1988年,no.5,pp.1263-1270

Also Published As

Publication number Publication date
GB2595355A (en) 2021-11-24
GB202215746D0 (en) 2022-12-07
US20230227390A1 (en) 2023-07-20
CN116194431B (zh) 2026-01-02
BR112022019616A2 (pt) 2022-12-06
KR20230121960A (ko) 2023-08-22
MX2022011832A (es) 2023-03-03
WO2021198692A1 (en) 2021-10-07
GB2609814A (en) 2023-02-15
US12552733B2 (en) 2026-02-17
CA3177186A1 (en) 2021-10-07
US20230225985A1 (en) 2023-07-20
AU2021248627A1 (en) 2022-12-01
GB202104690D0 (en) 2021-05-12
IL296861A (en) 2022-11-01
EP4126800A1 (en) 2023-02-08
GB2609814B (en) 2024-08-28
JP2023520794A (ja) 2023-05-19
CN116194431A (zh) 2023-05-30

Similar Documents

Publication Publication Date Title
JP7727733B2 (ja) 薬学的活性化合物としてのカンナビノイド誘導体及びその調製方法
EP4337632B1 (en) Resorcinol derivative as a pharmaceutically active compound and method of preparation thereof
TWI451870B (zh) 脂肪酸醯胺水解酶抑制劑
AU2022273928A1 (en) Derivatives of cannabidiol-c4 for the treatment of epilepsy
JP7714571B2 (ja) テルペンフェノール化合物およびそれらの使用
AU733264B2 (en) Aminotetralin derivatives and compositions and method of use thereof
RU2413715C2 (ru) Способ получения замещенных тетрафторбензиланилиновых соединений и их фармацевтически приемлемых солей
KR20210071949A (ko) 신경학적 질환 또는 미트콘드리아 질환 치료용 화합물
GB2628746A (en) Terpenophenolic compounds and their use
TW201738245A (zh) 具有抗癌活性之嘌呤化合物
CN109415285B (zh) 苯双酚衍生物及其制备方法和在医药上的应用
WO2025255358A1 (en) Solid forms of posiphen d-tartrate and processes of preparation thereof
Duncan et al. 2-(. omega.-Aminoalkyl)-4-tert-butyl-6-phenylphenols as antimalarial agents
van Aken Aliphatic nitro compounds in stereoselective synthesis: the development of a chiral catalyst

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221003

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240401

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240401

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241213

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250312

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250609

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250617

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250716

R150 Certificate of patent or registration of utility model

Ref document number: 7714571

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150